Brief: Biofrontera AG Says Will Terminate Its U.S. ADS Program
02/06/2022 18:59
June 2 (Reuters) - Biofrontera AG B8FGn.DE :
* WILL TERMINATE ITS U.S. ADS PROGRAM
* FOLLOWING TERMINATION OF DEPOSIT AGREEMENT, BNY MELLON
WILL
DISCONTINUE REGISTRATION OF TRANSFERS OF ADSS
* BIOFRONTERA - DELISTED ITS ADSS FROM NASDAQ CAPITAL MARKET
EFFECTIVE IN EARLY MARCH 2022 AND EXPECTED TO TAKE EFFECT ON OR
ABOUT JUNE 7, 2022
* PRIMARY INTENT OF DELISTING WAS TO REDUCE FINANCIAL
REPORTING
COMPLEXITY AND ADMINISTRATIVE COSTS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biofrontera AG
See all newsBrief: Biofrontera Says Co And Units Have Entered Into An Agreement With Biofrontera Inc About How To Settle Payment Obligations By Biofrontera Inc
Brief: Biofrontera AG Says Legal Dispute On Import In USA Will Result In Revised Outlook
Brief: Biofrontera AG Resolves Capital Increase From Authorized Capital
Brief: Biofrontera AG Says Plans Capital Reduction And Considers Subsequent Capital Increase From Authorized Capital
Brief: Biofrontera AG Says FY 2022 Total Revenue Amounted To EUR 25.7 Million